home / stock / tcbp / tcbp news


TCBP News and Press, TC BioPharm (Holdings) plc From 11/14/23

Stock Information

Company Name: TC BioPharm (Holdings) plc
Stock Symbol: TCBP
Market: NASDAQ
Website: tcbiopharm.com

Menu

TCBP TCBP Quote TCBP Short TCBP News TCBP Articles TCBP Message Board
Get TCBP Alerts

News, Short Squeeze, Breakout and More Instantly...

TCBP - TC BioPharm Announces Successful Completion of Safety Cohort and Positive DSMB Results

TC BioPharm Announces Successful Completion of Safety Cohort and Positive DSMB Results PR Newswire No Significant Safety Concerns Observed in Safety Cohort Management expects to expand ACHIEVE trial in Q1 EDINBURGH, Scotland , Nov. 14, 2023 /P...

TCBP - TC BioPharm Announces Streamlined Efficiencies and Reduces Overhead with Selection of Single Global CRO for Clinical Trials

TC BioPharm Announces Streamlined Efficiencies and Reduces Overhead with Selection of Single Global CRO for Clinical Trials PR Newswire Creates economic leverage with vertical integration of database and management EDINBURGH, Scotland , Nov. 2, 2023 /...

TCBP - TC BioPharm Selects Excellos as CDMO in Anticipation of Expanded US Clinical Trial Requirements

TC BioPharm Selects Excellos as CDMO in Anticipation of Expanded US Clinical Trial Requirements PR Newswire Excellos to provide scale up solution for final manufacturing in TCBP facility EDINBURGH, Scotland , Oct. 25, 2023 /PRNewswire/ -- TC Bio...

TCBP - Why the Relapsed/Refractory Acute Myeloid Leukemia Market is Expected to Witness Revolutionary Developments

2023-10-24 08:45:00 ET Palm Beach, FL – October 24, 2023 – FinancialNewsMedia.com News Commentary – Acute myeloid leukemia (AML) is a type of hematologic cancer that is distinguished by the clonal growth of myeloid blasts in the peripheral blood, bone marrow...

TCBP - TC BioPharm Announces Submission of Investigational New Drug (IND) Application to U.S. FDA for Treatment of Relapse/Refractory AML

TC BioPharm Announces Submission of Investigational New Drug (IND) Application to U.S. FDA for Treatment of Relapse/Refractory AML PR Newswire Filing is supported by strong clinical data and IND enabling pre-clinical data associated withTCB-008 in treatment of Acute Myeloid ...

TCBP - TC Biopharm files to sell 12.94M American Depositary Shares

2023-09-29 16:22:42 ET More on TC Biopharm Seeking Alpha’s Quant Rating on TC Biopharm Historical earnings data for TC Biopharm Financial information for TC Biopharm For further details see: TC Biopharm files to sell 12.94M American Depositary Shares

TCBP - TC BioPharm to Present at the LD Micro Main Event XVI

TC BioPharm to Present at the LD Micro Main Event XVI PR Newswire EDINBURGH, Scotland , Sept. 27, 2023 /PRNewswire/ -- TC BioPharm (Holdings) PLC ("TC BioPharm" or the "Company") (NASDAQ: TCBP) a clinical stage biotechnology company developing platform allog...

TCBP - TC BioPharm Announces Grant Funding in Collaboration with Queen Mary University of London (QMUL)

TC BioPharm Announces Grant Funding in Collaboration with Queen Mary University of London (QMUL) PR Newswire EDINBURGH, Scotland , Sept. 5, 2023 /PRNewswire/ -- TC BioPharm (Holdings) PLC ("TC BioPharm" or the "Company") (NASDAQ: TCBP), a clinical stage biotechno...

TCBP - Apellis Layoffs 2023: What to Know About the Latest APLS Job Cuts

2023-08-29 09:24:21 ET InvestorPlace - Stock Market News, Stock Advice & Trading Tips Apellis Pharmaceuticals (NASDAQ: APLS ) layoffs are a hot topic on Tuesday as the commercial-stage biopharmaceutical company prepares for job cuts . Apellis Pharmaceutic...

TCBP - Why Is TC BioPharm (TCBP) Stock Up Today?

2023-08-29 08:55:39 ET InvestorPlace - Stock Market News, Stock Advice & Trading Tips TC BioPharm (NASDAQ: TCBP ) stock is up on Tuesday after the clinical-stage biopharmaceutical company announced an upcoming presentation . According to a press relea...

Previous 10 Next 10